Trials / Conditions / Haemophilus Infections

Haemophilus Infections

9 registered clinical trials studyying Haemophilus Infections.

Status	Trial	Sponsor	Phase
Completed	A Comparison of the Immunogenicity and Safety of Quinvaxem in Mono-dose Vials and Uniject NCT01917357	Crucell Holland BV	Phase 3
Completed	Study to Assess if Quinvaxem Can be Interchanged With Other Pentavalent Vaccines During Standard Childhood Vac NCT01357720	Crucell Holland BV	Phase 4
Completed	Surveillance Program to Determine Product Specific Rates of Invasive Hib Disease NCT00855855	Sanofi Pasteur, a Sanofi Company	—
Completed	A Study to Gather Safety Data Following Administration of a Hib-containing Booster Vaccine in Children Aged Tw NCT00625118	Public Health England	—
Completed	Immunogenicity and Safety Study of Proquad® and Infanrix® Hexa When Administered Concomitantly (V221-035) NCT00432042	Merck Sharp & Dohme LLC	Phase 3
Completed	Comparison of DTaP-HB-PRP~T Combined Vaccine to Tritanrix-HepB/Hib™, Both Given Concomitantly With Oral Polio NCT00343889	Sanofi Pasteur, a Sanofi Company	Phase 3
Completed	Immunogenicity and Safety of Pentaxim™ in an Indian Population NCT00259337	Sanofi	Phase 3
Completed	Immunogenicity and Safety of Sanofi Pasteur Pentaxim Combined Vaccine in Infants in Thailand NCT00255021	Sanofi	Phase 4
Completed	Immunogenicity and Safety of Pentaxim in South African Infants NCT00254969	Sanofi	Phase 3